Tuberculosis remains the most deadly infectious diseases in the world. In particular, the growing number of multiresistant microbes is a cause of great concern to doctors and healthcare policymakers. At least a dozen candidate ...
Mar 23, 2018
0
3
Tuberculosis bacteria hide in the very cells that would normally kill them. Now we know more about how they evade recognition. Tuberculosis affects millions of people worldwide. Treatment is often prolonged, from six months ...
Sep 28, 2017
0
0
Global Tuberculosis Report, the disease kills over 1.5 million people a year. Although the mortality rate has dropped by 47% since 1990 due to advances in preventive and treatment options, the tuberculosis bacillus is growing ...
Jan 19, 2017
0
0
A clever new tuberculosis vaccine has shown promise in trials in mice. If it succeeds, it will be the first new TB vaccine in a century. With the rise of multidrug resistant tuberculosis, the difficulty of curing the disease, ...
Jan 13, 2017
0
0
In rich countries, tuberculosis is sometimes thought of as a thing of the past, the disease that claimed Keats, Poe, Chopin. But globally, TB is today the number one infectious killer, causing an estimated 1.8m deaths in ...
Oct 26, 2016
0
1
The HIV virus increases the potency of the tuberculosis bacterium (Mtb) by affecting a central function of the immune system. This is the conclusion of a study carried out by researchers at Linköping University in Sweden. ...
Oct 18, 2016
0
0
Scientists at the University of Sussex have unraveled a key process in the bacterium that causes tuberculosis (TB), potentially paving the way for new antibiotics to fight the disease.
Jun 30, 2015
0
15
Researchers at the University of Georgia have developed a new small molecule drug that may serve as a treatment against multi-drug resistant tuberculosis, a form of the disease that cannot be cured with conventional therapies. ...
Feb 20, 2015
0
13
"Living-dead" bacteria exist in limbo: biologically active but not proliferating. Buried in this zombie state, disease-causing bacteria could come back from the dead to re-infect patients. Researchers at EPFL have produced ...
Jan 26, 2015
0
17
A drug under clinical trials to treat tuberculosis could be the basis for a class of broad-spectrum drugs that act against various bacteria, fungal infections and parasites, yet evade resistance, according to a study by University ...
Apr 17, 2014
0
0
